429 related articles for article (PubMed ID: 17355265)
21. ADAMs and ADAMTSs in cancer.
Turner SL; Blair-Zajdel ME; Bunning RA
Br J Biomed Sci; 2009; 66(2):117-28. PubMed ID: 19637655
[TBL] [Abstract][Full Text] [Related]
22. Expression levels of the metalloproteinase ADAM8 critically regulate proliferation, migration and malignant signalling events in hepatoma cells.
Awan T; Babendreyer A; Mahmood Alvi A; Düsterhöft S; Lambertz D; Bartsch JW; Liedtke C; Ludwig A
J Cell Mol Med; 2021 Feb; 25(4):1982-1999. PubMed ID: 33314720
[TBL] [Abstract][Full Text] [Related]
23. The Biochemistry and Physiology of A Disintegrin and Metalloproteinases (ADAMs and ADAM-TSs) in Human Pathologies.
Sharma D; Singh NK
Rev Physiol Biochem Pharmacol; 2023; 184():69-120. PubMed ID: 35061104
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of MMPs and ADAM/ADAMTS.
Malemud CJ
Biochem Pharmacol; 2019 Jul; 165():33-40. PubMed ID: 30826330
[TBL] [Abstract][Full Text] [Related]
25. ADAM28 is overexpressed in human breast carcinomas: implications for carcinoma cell proliferation through cleavage of insulin-like growth factor binding protein-3.
Mitsui Y; Mochizuki S; Kodama T; Shimoda M; Ohtsuka T; Shiomi T; Chijiiwa M; Ikeda T; Kitajima M; Okada Y
Cancer Res; 2006 Oct; 66(20):9913-20. PubMed ID: 17047053
[TBL] [Abstract][Full Text] [Related]
26. ADAM8 in invasive cancers: links to tumor progression, metastasis, and chemoresistance.
Conrad C; Benzel J; Dorzweiler K; Cook L; Schlomann U; Zarbock A; Slater EP; Nimsky C; Bartsch JW
Clin Sci (Lond); 2019 Jan; 133(1):83-99. PubMed ID: 30635388
[TBL] [Abstract][Full Text] [Related]
27. ADAM-family metalloproteinases in lung inflammation: potential therapeutic targets.
Dreymueller D; Uhlig S; Ludwig A
Am J Physiol Lung Cell Mol Physiol; 2015 Feb; 308(4):L325-43. PubMed ID: 25480335
[TBL] [Abstract][Full Text] [Related]
28. Evolutionary divergence and functions of the ADAM and ADAMTS gene families.
Brocker CN; Vasiliou V; Nebert DW
Hum Genomics; 2009 Oct; 4(1):43-55. PubMed ID: 19951893
[TBL] [Abstract][Full Text] [Related]
29. Expression of members of the novel membrane linked metalloproteinase family ADAM in cells derived from a range of haematological malignancies.
Wu E; Croucher PI; McKie N
Biochem Biophys Res Commun; 1997 Jun; 235(2):437-42. PubMed ID: 9199213
[TBL] [Abstract][Full Text] [Related]
30. (Make) stick and cut loose--disintegrin metalloproteases in development and disease.
Tousseyn T; Jorissen E; Reiss K; Hartmann D
Birth Defects Res C Embryo Today; 2006 Mar; 78(1):24-46. PubMed ID: 16622847
[TBL] [Abstract][Full Text] [Related]
31. Role of ADAM and ADAMTS metalloproteinases in airway diseases.
Paulissen G; Rocks N; Gueders MM; Crahay C; Quesada-Calvo F; Bekaert S; Hacha J; El Hour M; Foidart JM; Noel A; Cataldo DD
Respir Res; 2009 Dec; 10(1):127. PubMed ID: 20034386
[TBL] [Abstract][Full Text] [Related]
32. Expression profiles and clinical correlations of degradome components in the tumor microenvironment of head and neck squamous cell carcinoma.
Stokes A; Joutsa J; Ala-Aho R; Pitchers M; Pennington CJ; Martin C; Premachandra DJ; Okada Y; Peltonen J; Grénman R; James HA; Edwards DR; Kähäri VM
Clin Cancer Res; 2010 Apr; 16(7):2022-35. PubMed ID: 20305301
[TBL] [Abstract][Full Text] [Related]
33. Expression and cellular localization of metalloproteases ADAMs in high graded carotid artery lesions.
Pelisek J; Pongratz J; Deutsch L; Reeps C; Stadlbauer T; Eckstein HH
Scand J Clin Lab Invest; 2012 Dec; 72(8):648-56. PubMed ID: 23101757
[TBL] [Abstract][Full Text] [Related]
34. ADAM9 is over-expressed in human ovarian clear cell carcinomas and suppresses cisplatin-induced cell death.
Ueno M; Shiomi T; Mochizuki S; Chijiiwa M; Shimoda M; Kanai Y; Kataoka F; Hirasawa A; Susumu N; Aoki D; Okada Y
Cancer Sci; 2018 Feb; 109(2):471-482. PubMed ID: 29247567
[TBL] [Abstract][Full Text] [Related]
35. RECK inhibits stemness gene expression and tumorigenicity of gastric cancer cells by suppressing ADAM-mediated Notch1 activation.
Hong KJ; Wu DC; Cheng KH; Chen LT; Hung WC
J Cell Physiol; 2014 Feb; 229(2):191-201. PubMed ID: 23881612
[TBL] [Abstract][Full Text] [Related]
36. Functional classification of ADAMs based on a conserved motif for binding to integrin alpha 9beta 1: implications for sperm-egg binding and other cell interactions.
Eto K; Huet C; Tarui T; Kupriyanov S; Liu HZ; Puzon-McLaughlin W; Zhang XP; Sheppard D; Engvall E; Takada Y
J Biol Chem; 2002 May; 277(20):17804-10. PubMed ID: 11882657
[TBL] [Abstract][Full Text] [Related]
37. Matrix metalloproteinases, a disintegrin and metalloproteinases, and a disintegrin and metalloproteinases with thrombospondin motifs in non-neoplastic diseases.
Shiomi T; Lemaître V; D'Armiento J; Okada Y
Pathol Int; 2010 Jul; 60(7):477-96. PubMed ID: 20594269
[TBL] [Abstract][Full Text] [Related]
38. ADAM9 silencing inhibits breast tumor cells transmigration through blood and lymphatic endothelial cells.
Micocci KC; Moritz MN; Lino RL; Fernandes LR; Lima AG; Figueiredo CC; Morandi V; Selistre-de-Araujo HS
Biochimie; 2016; 128-129():174-82. PubMed ID: 27554339
[TBL] [Abstract][Full Text] [Related]
39. Increased expression of ADAM family members in human breast cancer and breast cancer cell lines.
Lendeckel U; Kohl J; Arndt M; Carl-McGrath S; Donat H; Röcken C
J Cancer Res Clin Oncol; 2005 Jan; 131(1):41-8. PubMed ID: 15565459
[TBL] [Abstract][Full Text] [Related]
40. Expression of a disintegrin and metalloprotease (ADAM and ADAMTS) enzymes in human non-small-cell lung carcinomas (NSCLC).
Rocks N; Paulissen G; Quesada Calvo F; Polette M; Gueders M; Munaut C; Foidart JM; Noel A; Birembaut P; Cataldo D
Br J Cancer; 2006 Mar; 94(5):724-30. PubMed ID: 16495931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
